Prior Failed Attempts
Section 07
Section 7A
Section 7B

Summary of Prior Failed Efforts to Publish the “Liver-Brain-Theory"

The author submitted a 134 word hypothesis, along with supplemental Information, directly to the Editor in Chief of the New England Journal of Medicine on 9/7/2014. He received the following rejection letter (9/15/2014) in the return mail:

See 7B, Immediately following;

Please note the comments by Dr. Drazen concerning a possible liver transplant.  Sachatello’s Liver-Brain-Theory makes the heretical proposal that a liver replacement may very well arrest the progression of the muscle wasting diagnostic of ALS.   This concept was a logical conclusion of the unproved premise that hepatic generated neurotoxins were the proximate cause of most types of neurodegenerative diseases.

The author was initially dismayed to see this rejection letter. On re-reading it however, he was pleased that Dr. Drazen’s note confirmed his research findings: the NEJM had never published any theory attempting to explain the cause of any type of neurodegenerative disease in the preceding one hundred years or more.

Not at all discouraged by this initial rejection of this hypothesis, the author proceeded to attempt to publish a similar version of the Liver-Brain-Theory in “NEUROLOGY®."

On November 12, 2014, the author received several separate emails from their editorial staff: “Your manuscript will not be considered for publication, until you have approved the submission.”

Seven days later, November 19, 2014, 9:30 AM, the author received a formal notice (via email) from the office of the Editor in Chief:  “Your manuscript has been reviewed by one or more of the editors and is being returned without review: “we regret that this decision is final.”

Having no other acceptable option to publish this theory  elsewhere, the author elected to publish it online: www.Liver-Brain-Theory.com

The author of this theory personally encourages everyone to shred his heretical ideas to pieces! It should be very simple to those in the know, especially the so called "experts", to prove that this Liver Brain Theory is Categorically Implausible!

Anticipated Reaction and Rejection of this Heretical Theory

It is only natural that these ideas be viewed with skepticism and disbelief by all students of neurodegenerative diseases.  Every neurologist in the world has been educated and has learned from his own personal clinical experience: ALS is a totally incurable disease. Death will occur with certainty within 24 -60 months of the initial diagnosis in 95% of his patients. 

The heretical idea that a liver transplant could possibly arrest the inevitable progression of muscle weakness in ALS is not based on any laboratory experience or experiments. It is the conceptual work product of the mind of a single Individual: one with no credentials whatsoever in the art or science of Neurology. Why does this upstart deserve any credibility what so ever?

Surely such thinking occurred in the upper echelons of the ALS Organization when they elected not to post these ideas on their website.

The authors response:  If the basic premise of the Liver-Brain-Theory is correct: "that it is an aging liver, not an aging brain or neurons, that promotes the development of neurodegenerative diseases" then the following study should be done for the benefit of both ALS and Alzheimer's patients as soon as practical.

Proposed Clinical Study

There are more than 100,000 patients alive today with a liver transplant. There is an enormous variability between the chronological age of the host and of the chronological age of the new liver in the majority of transplant patients. In the author case, his new liver is 37 years younger than he is.

Alzheimer's disease presents more meaningful data in specific clinical areas: the well recognized increased incidence in Caucasian females, versus males: (nearly 2 to 1). Similarly Alzheimer's disease is truly a disease of aging.   It is rarely diagnosed clinically before age 60-65.

The probability of a liver transplant patient developing Alzheimer’s  should correlate directly with the age and sex of the transplanted liver rather than the chronological age of its host.

Should these clinical studies be confirmed, as the author anticipates they will, it will lend additional support to approving an experimental liver transplant in an otherwise healthy patient with ALS, an inevitably fatal disease.

Nevertheless, a patient, Lou Gehrig’s age (35) should not be denied the opportunity to submit himself to an experimental liver transplant hoping to arrest the progressive loss of muscle strength and possibility avoid his otherwise certain premature death from ALS in view of the fact that ALS is still a disease without know cause or cure after its original description nearly 200 years ago in 1824.

Updated and revised: 11/15/2017


←  Go Back to Previous Section Continue to Next Section  →